Search

Displaying results 8691 - 8700 of 10000 in total
  1. Drug

    Ferulic acid

    go.drugbank.com/drugs/DB07767
    Investigational

    Categories: Indicators and Reagents, Cholagogues and Choleretics
  2. Drug

    Vurolenatide

    go.drugbank.com/drugs/DB18440
    Investigational

    Vurolenatide is a recombinant fusion protein comprising exenatide and XTEN.

  3. Drug

    Rebaudioside A

    go.drugbank.com/drugs/DB15136
    Investigational

    Rebaudioside A is under investigation in clinical trial NCT03510624 (Acute Effect of Rebaudioside A on Glucose Excursion During an Oral Glucose Tolerance Test in Type 2 Diabetes Mellitus).

  4. Drug

    Dendritic cells vaccine

    go.drugbank.com/drugs/DB15803
    Investigational

    , and incomplete viral inactivation. … With a better safety profile than inactivated and live-attenuated virus and virus-vector vaccines, the recombinant chimeric DC vaccine reduces the risk of virulence recovery, pre-existing anti-vector immunity

  5. Drug

    PI-166

    go.drugbank.com/drugs/DB05859
    Experimental

    It has demonstrated the ability to reduce the growth of rat hepatomas, which is like human hepatomas, are resistant to established anti-cancer agents. … PI-166 is a small organic compound with specific avidity to liver cancer cells.

  6. Drug

    Sulfamoxole

    go.drugbank.com/drugs/DB08798
    Experimental

    Sulfamoxole is an antibacterial in the sulfonamide class.

    Categories: sulfamoxole and trimethoprim, Sulfonamides and trimethoprimSynonyms: N1-(4,5-Dimethyl-2-oxazolyl)sulfanilamide, N(sup 1)-(4,5-Dimethyl-2-oxazolyl)sulfanilamide
  7. Drug

    FB-825

    go.drugbank.com/drugs/DB17598
    Investigational

    It is currently being investigated for immune disorders, such as atopic dermatitis and hyperimmunoglobulin E syndrome (HIES).[A258448,L45743] … FB-825 is an investigational humanized monoclonal antibody that targets the CεmX domain of the membrane-bound IgE (mIgE), causing a depletion of mIgE positive B-cells.

  8. Drug

    PT217

    go.drugbank.com/drugs/DB18472
    Investigational

    PT217 is a bispecific Antibody against DLL3 and CD47

  9. Drug

    PF-05089771

    go.drugbank.com/drugs/DB14856
    Investigational

    PF-05089771 is under investigation in clinical trial NCT01529671 (A Safety And Tolerability Study Of PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee).

  10. Drug

    Novaferon

    go.drugbank.com/drugs/DB16483
    Investigational

    Categories: Amino Acids, Peptides, and Proteins, Intercellular Signaling Peptides and Proteins